Press release
Top Factor Driving Non-Insulin Therapies For Diabetes Market Growth in 2025: Role of Non-Insulin Therapies in Addressing the Global Diabetes Epidemic
Non-Insulin Therapies For Diabetes Market Size
The market size for non-insulin diabetes therapies has substantially expanded in the past few years. The market, which was worth $19.98 billion in 2024, is projected to surge to $21.41 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%. The noticeable growth during the historical period can be tied back to the heightened prevalence of diabetes, increased knowledge about diabetes treatment, a spike in healthcare spending, lifestyle alterations leading to greater incidence rates, a rise in diagnoses, enhanced government endeavors for diabetes management, and a boost in pharmaceutical research and development investment.
Expectations are high for the non-insulin diabetes therapies market, with strong growth anticipated over the next several years. Predicted to reach $27.9 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 6.8%, various factors contribute to this expected growth. Among these are increased rates of diabetes, heightened awareness surrounding diabetes management, the growing use of combination therapies, a rising elderly population, an increase in healthcare expenses, the extension of telemedicine, and a shifted preference towards oral medications. In the upcoming years, the major trends to watch for are advancements in both oral and injectable medicines, improvements in drug delivery systems and oral peptide delivery, increased use of telemedicine and digital health solutions, and continued progress in combination therapies.
What Are the Main Catalysts for Growth in the Non-Insulin Therapies For Diabetes Market?
The rise in diabetes cases is anticipated to spur the expansion of non-insulin treatments in the diabetes market. Diabetes, a chronic health problem characterized by elevated levels of blood sugar, results from the body's inability to produce sufficient insulin or adequately utilize the insulin it has. The rising incidence of diabetes can be attributed to inactive lifestyles, poor diet habits, genetic factors, aging populations, obesity, ethnic factors, lack of knowledge, inadequate access to healthcare, and environmental aspects. Non-insulin diabetes treatments aim to manage the disease by enhancing insulin receptiveness, minimizing liver glucose production, boosting glucose absorption in muscle cells, and improving overall blood sugar control. As an illustration, The British Diabetic Association reported in April 2023 that 4.3 million people in the UK had been diagnosed with diabetes. Registration records from 2021-22 indicate an increase of 148,951 cases relative to 2020-21. Moreover, over 2.4 million UK residents are at a significant risk of contracting type 2 diabetes. Consequently, the growing prevalence of diabetes is fuelling the expansion of non-insulin treatments in the diabetes market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16494&type=smp
Who Are the Dominant Companies Influencing Non-Insulin Therapies For Diabetes Market Trends?
Major companies operating in the non-insulin therapies for diabetes market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Sanofi, The Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, GSK plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Les Servier Laboratories, Sumitomo Dainippon Pharma Co. Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Uni-Bio Science Group Ltd., Intarcia Therapeutics, Janssen Pharmaceuticals, Boan Biotech, SatRx LLC
How Is the Non-Insulin Therapies For Diabetes Market Evolving?
Leading enterprises in the non-insulin diabetes therapies marketplace are focusing on the development of tailor-made diabetes oversight systems to improve patient results via live tracking, interpreting data and personalizing treatment approaches. Such bespoke diabetes management systems modify care and supervision according to the specific requirements of each patient, exploiting real-time data analysis to optimize healthcare and outcomes. For example, in November 2022, Eli Lilly and Company, an American pharmaceutical company, introduced the Tempo tailor-made diabetes management system. This platform consists of three key parts: the Tempo Smart Button, the TempoSmart application, and the preloaded insulin pen known as the Tempo Pen. These elements work together to offer customized advice to adults suffering from diabetes. This innovative platform is engineered to aid adults with diabetes type 1 or 2, and their medical practitioners, in making well-informed, evidence-based treatment choices using Lilly insulins.
What Are the Different Segmentations in the Non-Insulin Therapies For Diabetes Market?
The non-insulin therapies for diabetes market covered in this report is segmented -
1) By Drug Class: Biguanides, Sulfonylureas, Thiazolidinedione's, Alpha-Glucosidase Inhibitors, Dipeptidyl peptidase-4 (DPP-4) Inhibitors, Glucagon-like peptide-1 (GLP-1) Analogs, Sodium-glucose co-transporter-2 (SGLT2) Inhibitors
2) By Route Of Administration: Oral, Intramuscular
3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy
4) By Application: Monitoring, Diagnosis, Treatment, Other Applications
Subsegments:
1) By Biguanides: Metformin, Combination Of Metformin With Other Drugs
2) By Sulfonylureas: Glimepiride, Glipizide, Glyburide
3) By Thiazolidinediones: Pioglitazone, Rosiglitazone
4) By Alpha-Glucosidase Inhibitors: Acarbose, Miglitol
5) By Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin
6) By Glucagon-Like Peptide-1 (GLP-1) Analogs: Exenatide, Liraglutide, Dulaglutide, Semaglutide
7) By Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors: Canagliflozin, Dapagliflozin, Empagliflozin
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/non-insulin-therapies-for-diabetes-global-market-report
Which Region Is at the Forefront of the Non-Insulin Therapies For Diabetes Market?
North America was the largest region in the non-insulin therapies for diabetes market in 2024. The regions covered in the non-insulin therapies for diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Non-Insulin Therapies For Diabetes Global Market Report?
- Market Size Analysis: Analyze the Non-Insulin Therapies For Diabetes Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Non-Insulin Therapies For Diabetes Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Non-Insulin Therapies For Diabetes Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Non-Insulin Therapies For Diabetes Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16494
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Top Factor Driving Non-Insulin Therapies For Diabetes Market Growth in 2025: Role of Non-Insulin Therapies in Addressing the Global Diabetes Epidemic here
News-ID: 3863719 • Views: …
More Releases from The Business Research Company
Percutaneous Puncture Surgery Robot Market Analysis Highlights Growth To $3.54 B …
The market for percutaneous puncture surgery robots is on the verge of significant expansion, driven by rapid technological advances and increasing adoption in healthcare settings. As robotic systems become more sophisticated and integrated with cutting-edge technologies, this sector is set to transform minimally invasive surgical procedures. Below is a detailed exploration of the market's size, key players, trends, and segmentation that shape its future trajectory.
Projected Growth and Market Size of…
Pedicle Screw Systems Market Study Highlights How Industry Demand Is Evolving
The pedicle screw systems market is set to experience significant expansion in the coming years, driven by advancements in spinal surgery techniques and increasing patient demand. This market's evolution reflects growing medical needs and ongoing innovation, positioning it for substantial growth by 2030.
Forecasted Market Size and Growth Trajectory for Pedicle Screw Systems
The value of the pedicle screw systems market is projected to reach $7.65 billion by 2030, growing…
Pediatric Orthopedic Implants Market Research Reveals Strong 10.8% CAGR Outlook …
The pediatric orthopedic implants market is on track for significant expansion as advancements in technology and growing healthcare needs drive demand. Innovations in implant design and personalized treatment options are setting the stage for transformative growth in this specialized segment of medical devices. Below is a detailed overview of the current market size, key industry players, emerging trends, and segmentation that define this market's future.
Pediatric Orthopedic Implants Market Size and…
Pediatric Interventional Cardiology Market Intelligence Report Covers Trends, Se …
The pediatric interventional cardiology field is on track for significant expansion, driven by advances in medical technology and growing demand for specialized cardiac care for children. This sector is expected to see dynamic growth as innovative devices and techniques become more widely adopted to improve patient outcomes.
Projected Market Size and Growth Trajectory of the Pediatric Interventional Cardiology Market
The market for pediatric interventional cardiology is forecasted to grow steadily,…
More Releases for Diabetes
Diabetes Software Market Revolution: Advancing Intelligent Digital Diabetes Care
The global Diabetes Software Market is witnessing significant transformation as healthcare systems increasingly embrace digital technologies to improve chronic disease management and patient outcomes. The growing need for continuous glucose monitoring, remote patient engagement, and data-driven clinical decision-making has accelerated the adoption of advanced diabetes software solutions across hospitals, clinics, and home care settings. These platforms are helping healthcare providers streamline treatment workflows while enabling patients to actively participate in…
Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size?
The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools.
The diabetes pen market is projected to grow strongly, reaching $40.17 billion…
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges…
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28).
According to Type-2 Diabetes Market…
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face.
Dr. Marlene Merritt (from the Merritt Wellness Center in…
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system.
As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important.
The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end…
